Browse By Cell Line Result Page of OvirusTdb

The total number of records retrieved from this search are 16. Click on ID to see further detail.
IDOV_2427Virus nameVaccinia virusVirus strainGLV-1h151Virus genome typeDNAVirus familyPoxviridaeVirus genome modificationDeteltion of TK gene and addition of GFP geneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman squamous cell lineCell lineSCC-25Concentration of cell line3.0E+4 cells per wellIn-vitro toxicityNAAssayLDH release and spectrophometerIn-vitro virus concentration0.01 MOIIn-vitro result100% cell survival after day 1Model organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedNAImmunogenic effectNAClinical trialNAPMID22258815
IDOV_2428Virus nameVaccinia virusVirus strainGLV-1h151Virus genome typeDNAVirus familyPoxviridaeVirus genome modificationDeteltion of TK gene and addition of GFP geneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman squamous cell lineCell lineSCC-25Concentration of cell line3.0E+4 cells per wellIn-vitro toxicityNAAssayLDH release and spectrophometerIn-vitro virus concentration0.01 MOIIn-vitro result100% cell survival after day 3Model organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedNAImmunogenic effectNAClinical trialNAPMID22258815
IDOV_2429Virus nameVaccinia virusVirus strainGLV-1h151Virus genome typeDNAVirus familyPoxviridaeVirus genome modificationDeteltion of TK gene and addition of GFP geneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman squamous cell lineCell lineSCC-25Concentration of cell line3.0E+4 cells per wellIn-vitro toxicityNAAssayLDH release and spectrophometerIn-vitro virus concentration0.01 MOIIn-vitro result100% cell survival after day 5Model organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedNAImmunogenic effectNAClinical trialNAPMID22258815
IDOV_2430Virus nameVaccinia virusVirus strainGLV-1h151Virus genome typeDNAVirus familyPoxviridaeVirus genome modificationDeteltion of TK gene and addition of GFP geneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman squamous cell lineCell lineSCC-25Concentration of cell line3.0E+4 cells per wellIn-vitro toxicityNAAssayLDH release and spectrophometerIn-vitro virus concentration0.01 MOIIn-vitro result50% cell killing after day 7Model organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedNAImmunogenic effectNAClinical trialNAPMID22258815
IDOV_2431Virus nameVaccinia virusVirus strainGLV-1h151Virus genome typeDNAVirus familyPoxviridaeVirus genome modificationDeteltion of TK gene and addition of GFP geneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman squamous cell lineCell lineSCC-25Concentration of cell line3.0E+4 cells per wellIn-vitro toxicityNAAssayLDH release and spectrophometerIn-vitro virus concentration0.01 MOIIn-vitro result60% cell killing after day 9Model organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedNAImmunogenic effectNAClinical trialNAPMID22258815
IDOV_2467Virus nameVaccinia virusVirus strainGLV-1h151Virus genome typeDNAVirus familyPoxviridaeVirus genome modificationDeteltion of TK gene and addition of GFP geneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman squamous cell lineCell lineSCC-25Concentration of cell line3.0E+4 cells per wellIn-vitro toxicityNAAssayLDH release and spectrophometerIn-vitro virus concentration0.10 MOIIn-vitro result100% cell survival after day 1Model organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedNAImmunogenic effectNAClinical trialNAPMID22258815
IDOV_2468Virus nameVaccinia virusVirus strainGLV-1h151Virus genome typeDNAVirus familyPoxviridaeVirus genome modificationDeteltion of TK gene and addition of GFP geneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman squamous cell lineCell lineSCC-25Concentration of cell line3.0E+4 cells per wellIn-vitro toxicityNAAssayLDH release and spectrophometerIn-vitro virus concentration0.10 MOIIn-vitro result90% cell survival after day 3Model organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedNAImmunogenic effectNAClinical trialNAPMID22258815
IDOV_2469Virus nameVaccinia virusVirus strainGLV-1h151Virus genome typeDNAVirus familyPoxviridaeVirus genome modificationDeteltion of TK gene and addition of GFP geneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman squamous cell lineCell lineSCC-25Concentration of cell line3.0E+4 cells per wellIn-vitro toxicityNAAssayLDH release and spectrophometerIn-vitro virus concentration0.10 MOIIn-vitro result50% cell survival after day 5Model organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedNAImmunogenic effectNAClinical trialNAPMID22258815
IDOV_2470Virus nameVaccinia virusVirus strainGLV-1h151Virus genome typeDNAVirus familyPoxviridaeVirus genome modificationDeteltion of TK gene and addition of GFP geneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman squamous cell lineCell lineSCC-25Concentration of cell line3.0E+4 cells per wellIn-vitro toxicityNAAssayLDH release and spectrophometerIn-vitro virus concentration0.10 MOIIn-vitro result40% cell survival after day 7Model organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedNAImmunogenic effectNAClinical trialNAPMID22258815
IDOV_2471Virus nameVaccinia virusVirus strainGLV-1h151Virus genome typeDNAVirus familyPoxviridaeVirus genome modificationDeteltion of TK gene and addition of GFP geneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman squamous cell lineCell lineSCC-25Concentration of cell line3.0E+4 cells per wellIn-vitro toxicityNAAssayLDH release and spectrophometerIn-vitro virus concentration0.10 MOIIn-vitro result30% cell survival after day 9Model organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedNAImmunogenic effectNAClinical trialNAPMID22258815
IDOV_2504Virus nameVaccinia virusVirus strainGLV-1h151Virus genome typeDNAVirus familyPoxviridaeVirus genome modificationDeteltion of TK gene and addition of GFP geneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman squamous cell lineCell lineSCC-25Concentration of cell line3.0E+4 cells per wellIn-vitro toxicityNAAssayLDH release and spectrophometerIn-vitro virus concentration1 MOIIn-vitro result50% cell survival after day 1Model organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedNAImmunogenic effectNAClinical trialNAPMID22258815
IDOV_2505Virus nameVaccinia virusVirus strainGLV-1h151Virus genome typeDNAVirus familyPoxviridaeVirus genome modificationDeteltion of TK gene and addition of GFP geneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman squamous cell lineCell lineSCC-25Concentration of cell line3.0E+4 cells per wellIn-vitro toxicityNAAssayLDH release and spectrophometerIn-vitro virus concentration1 MOIIn-vitro result20% cell survival after day 3Model organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedNAImmunogenic effectNAClinical trialNAPMID22258815
IDOV_2506Virus nameVaccinia virusVirus strainGLV-1h151Virus genome typeDNAVirus familyPoxviridaeVirus genome modificationDeteltion of TK gene and addition of GFP geneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman squamous cell lineCell lineSCC-25Concentration of cell line3.0E+4 cells per wellIn-vitro toxicityNAAssayLDH release and spectrophometerIn-vitro virus concentration1 MOIIn-vitro result100% cell death after day 5Model organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedNAImmunogenic effectNAClinical trialNAPMID22258815
IDOV_2507Virus nameVaccinia virusVirus strainGLV-1h151Virus genome typeDNAVirus familyPoxviridaeVirus genome modificationDeteltion of TK gene and addition of GFP geneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman squamous cell lineCell lineSCC-25Concentration of cell line3.0E+4 cells per wellIn-vitro toxicityNAAssayLDH release and spectrophometerIn-vitro virus concentration1 MOIIn-vitro result100% cell death after day 7Model organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedNAImmunogenic effectNAClinical trialNAPMID22258815
IDOV_2508Virus nameVaccinia virusVirus strainGLV-1h151Virus genome typeDNAVirus familyPoxviridaeVirus genome modificationDeteltion of TK gene and addition of GFP geneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman squamous cell lineCell lineSCC-25Concentration of cell line3.0E+4 cells per wellIn-vitro toxicityNAAssayLDH release and spectrophometerIn-vitro virus concentration1 MOIIn-vitro result100% cell death after day 9Model organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedNAImmunogenic effectNAClinical trialNAPMID22258815
IDOV_2978Virus nameReovirusVirus strainwild typeVirus genome typeRNAVirus familyReoviridaeVirus genome modificationNoneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman neck and squamous carcinoma cell lineCell lineSCC-25Concentration of cell line7.68E+3 cells per wellIn-vitro toxicityNAAssayAlamar blue assayIn-vitro virus concentration2.4 × 10⁸ pfuIn-vitro result54.6 +/- 21.5% cell viable after 96 hoursModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedNAImmunogenic effectNAClinical trialNAPMID25890191